期刊文献+

正五聚蛋白3与特发性扩张型心肌病的相关性 被引量:5

Relationship between PTX3 and idiopathic dilated cardiomyopathy
原文传递
导出
摘要 目的:研究正五聚蛋白(PTX)3与特发性扩张型心肌病的相关性。方法:选择30例特发性扩张型心肌病患者为病例组,30例同期健康体检者为对照组。采用酶联免疫吸附法检测血浆中PTX3、抗β1肾上腺素受体抗体、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6、超敏C反应蛋白(hs-CRP)以及人N端前脑钠素(NT-proBNP)水平,并进行心功能分级,测量左室舒张末期内径(LVEDD)及左室射血分数(LVEF)。比较2组PTX3水平,并对病例组中PTX3水平与其他指标进行相关性分析,同时对病例组中PTX3与hs-CRP的特异性和敏感性进行比较。结果:病例组血浆PTX3水平显著高于对照组[(3.39±2.57)ng/ml∶(1.18±0.77)ng/ml),P<0.01]。病例组中,心功能Ⅲ级、Ⅳ级血浆PTX3水平均明显高于对照组[(2.53±0.84)ng/ml∶(1.18±0.77)ng/ml,(4.64±3.66)ng/ml∶(1.18±0.77)ng/ml,均P<0.05],且心功能Ⅳ级PTX3水平高于心功能Ⅲ级(P<0.05)。病例组中血浆PTX3水平与抗β1肾上腺素受体抗体(r=0.551,P=0.001)、hs-CRP(r=0.600,P=0.005)、TNF-α(r=0.775,P=0.000)、IL-6(r=0.514,P=0.006)、NT-proBNP(r=0.453,P=0.004)及LVEDD(r=0.546,P=0.002)均呈正相关,与LVEF(r=-0.582,P=0.001)呈负相关。利用ROC曲线下面积对病例组中血浆PTX3与hs-CRP的灵敏性和特异性比较发现,PTX3和hs-CRP的ROC曲线下面积分别为0.932和0.686。结论:扩张型心肌病患者血浆PTX3水平升高,随心功能分级的增加而增加。血浆PTX3对扩张型心肌病炎性活动识别的敏感性和特异性优于hs-CRP,可作为扩张型心肌病较好的一个炎症指标。 Objective: To investigate the relationship between PTX3 and idiopathic dilated cardiomyopathy (IDCM). Method: Thirty IDCM patients (case group) and thirty healthy controls (control group) were enrolled. The PTX3, TNF-β, IL-6, hs-CRP, β1 adrenergic receptor autoantibodies and NT-proBNP were measured by sandwich ELISA. Heart function of patients in case group was classified, and the LVEDD and LVEF were measured. The relationship between PTX3 and other indicators were analyzed. The specificity and sensibility of PTX3 and hs-CRP were compared in case group. Result: PTX3 in case group was significantly higher than that in control group [(3.39±2.57) ng/ml vs (1. 18±0.77)ng/ml, P〈0.01]. In case group, PTX3 in NYHA III and IV were significantly higher than those in control group [(2.53±0.84)ng/ml vs (1.18±0. 77)ng/ml, (4.64±3.66)ng/ ml vs (1.18±0. 77)ng/ml, both P〈0. 057, and PTX3 in NYHA IV was significantly higher than that in NYHA III (P〈0.05). There was positive correlation between plasma PTX3 and β1 adrenergic receptor autoantibodies (r=0. 551, P=0. 001), hs-CRP (r=0. 600, P=0. 005), TNF-a (r=0. 775, P=0. 000), IL-6 (r=0. 514, P= 0. 006), NT-proBNP (r=0. 453, P=0. 004) and LVEDD (r=0. 546, P=0. 002), and there was negative correlation between plasma PTX3 and LVEF (r=-0. 582, P=0. 001). The areas under ROC curve of plasma PTX3 and hs-CRP were respectively 0. 932 and 0. 686. Conclusion:The plasma PTX3 in IDCM is significantly higher, and it is increased dependently on the severity of NYHA. The specificity and sensibility of plasma PTX3 is superior to hs CRP in the diagnosis of IDCM, and it may be a better inflammation marker.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第2期105-108,共4页 Journal of Clinical Cardiology
关键词 特发性扩张型心肌病 正五聚蛋白3 心力衰竭 idiopathic dilated cardiomyopathy PTX3 heart failure
  • 相关文献

参考文献7

二级参考文献36

  • 1贺忠梅,李美霞,王晓樑,武烨,燕子,王晋萍,刘慧荣.扩张型心肌病患者血清抗β_1肾上腺素受体自身抗体生物学效应[J].山西医科大学学报,2005,36(5):577-580. 被引量:12
  • 2张宏考,熊常初.生脉保元汤体内抗柯萨奇B3病毒的实验研究[J].郧阳医学院学报,2004,23(4):208-210. 被引量:5
  • 3Limas CJ, Goldenberg IF, Limas C. Autoantibodies against betaadrenoreceptors in human dilated cardiomyopathy [ J ]. Circ Res, 1989, 64(1) :97 -103.
  • 4Magnusson Y, Wallukat G, Waagstein F, et al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect[ J ]. Circulation, 1994, 89 (6) :2760 - 2767.
  • 5方 静,姜 建,罗德诚.生脉口服液对冠心病患者的心功能效应[J].中华内科杂志,1987,26(7):403-406.
  • 6Pankuweit S, Ruppert V, Maisch B. Inflammation in dilated cardiomyopathy. Herz,2004,29 (8) :788 - 793.
  • 7Kavsak PA, MacRae AR, Newman AM, et al. Elevated C - reactive protein in acute coronary syndrome presentation is an independent predictor of long- term mortality and heart failure. Clin Biochem,2007, 40(5/6) :326 - 329.
  • 8Anand IS, Latini R, Florea VG,et al. C - reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation,2005, 112(10) :1428 -1434.
  • 9Ishikawa C, Tsutamoto T, Fujii M,et al. Prediction of Mortality by High- Sensitivity C -Reactive Protein and Brain Natriuretic Peptide in Patients With Dilated Cardiomyopathy. Cite J, 2006,70(7) :857 - 863.
  • 10Pearson TA,Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation ,2003,107 ( 3 ) :499 - 511.

共引文献34

同被引文献33

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部